IP Library Granted Patent US 9,145,562
Granted Patent B2
US 9,145,562 · App. 12/592,195 · Granted Sep 29, 2015

Variegation in plants

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,145,562
App. No.
12/592,195
Granted
Sep 29, 2015
Kind
B2
Abstract

A variegated plant comprising a nucleic acid operatively linked to a regulatory region, the nucleic acid disrupts the expression of Cpn21. The nucleic acid is typically an antisense Cpn21 and the regulatory region may be an inducible regulatory region, a tissue specific regulatory region, or a developmental regulatory region.

Claims (21)

1. A plant comprising a heterologous nucleic acid operatively linked to a regulatory region, wherein the nucleic acid comprises the reverse complement of the sequence as set forth in SEQ ID NO: 1, and disrupts the expression of Cpn21 having the nucleotide sequence set forth in SEQ ID NO: 1 or an amino acid sequence comprising at least 61% identity to the amino acid sequence encoded by SEQ ID NO:1; and

wherein the plant exhibits a variegated phenotype and produces viable seed.

2. The plant of claim 1 , wherein the regulatory region is an inducible regulatory region, a tissue specific regulatory region, a developmental regulatory region or a constitutive regulatory region.

3. The plant of claim 2 , wherein the inducible regulatory region is an alcohol-inducible promoter.

4. The plant of claim 2 , wherein the tissue specific regulatory region is a RuBisCO promoter.

5. The plant of claim 1 , wherein RNA transcribed from the nucleic acid produces a double-stranded RNA (dsRNA).

6. A method of producing a plant exhibiting a variegated phenotype, the method comprising,

i) providing the plant comprising a heterologous nucleic acid operatively linked to a regulatory region, the nucleic acid comprising the reverse complement of the sequence as set forth in SEQ ID NO: 1, and disrupting the expression of Cpn21 having the nucleotide sequence set forth in SEQ ID NO: 1 or an amino acid sequence comprising at least 61% identity to the amino acid sequence encoded by SEQ ID NO:1, and

ii) growing the plant under conditions that results in the expression of the nucleic acid, thereby producing the plant having the variegated phenotype, wherein the plant produces viable seed.

7. The method of claim 6 , wherein the regulatory region is an inducible regulatory region, a tissue specific regulatory region, a developmental regulatory region or a constitutive regulatory region.

8. A method of selecting a plant comprising a gene of interest comprising,

i) providing the plant comprising a first heterologous nucleic acid operatively linked to a first regulatory region, wherein the first heterologous nucleic acid comprises the reverse complement of the sequence as set forth in SEQ ID NO: 1, and disrupts the expression of Cpn21 having the nucleotide sequence set forth in SEQ ID NO: 1 or an amino acid sequence comprising at least 61% identity to the amino acid sequence encoded by SEQ ID NO:1, and a second nucleic acid comprising the gene of interest and operatively linked to a second regulatory region,

ii) growing the plant under conditions that result in the expression of the first and second nucleic acids, and

iii) selecting plants that display a variegated phenotype and produce viable seed.

9. The method of claim 8 , wherein the first regulatory region is an inducible regulatory region, a tissue specific regulatory region, a developmental regulatory region or a constitutive regulatory region.

10. The method of claim 9 wherein the inducible regulatory region is alcohol-inducible.

11. The method of claim 8 , wherein the first regulatory region comprises an AlcA promoter and the gene of interest is AlcR.

12. The method of claim 6 wherein the regulatory region comprises a RuBisCO promoter.

13. The method of claim 6 wherein the regulatory region comprises an AlcA promoter.

14. The method of claim 6 wherein the regulatory region comprises a vein-specific promoter.

15. A seed that produces the plant of claim 1 .

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2017
From: ALBERTA INNOVATES
To: INNOTECH ALBERTA INC.
Reel/Frame 044935/0144 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED ON REEL 043315 FRAME 0074. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Sep 8, 2017
From: ALBERTA INNOVATES - TECHNOLOGY FUTURES
To: ALBERTA INNOVATES
Reel/Frame 043790/0646 →
CHANGE OF NAME Recorded Jul 24, 2017
From: ALBERTA INNOVATES - TECHNOLOGY FUTURE
To: ALBERTA INNOVATES
Reel/Frame 043315/0074 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S NAME PREVIOUSLY RECORDED ON REEL 023932 FRAME 0874. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNEE'S NAME SHOULD BE ALBERTA RESEARCH COUNCIL INC., AND NOT ALBERTA RSEARCH COUNCIL INC.. Recorded Sep 12, 2011
From: VELCHEVA, MARGARITA; VIDMAR, JOHN; QUANDT, JURGEN
To: ALBERTA RESEARCH COUNCIL INC.
Reel/Frame 026889/0906 →
NUNC PRO TUNC ASSIGNMENT Recorded Dec 16, 2010
From: ALBERTA RESEARCH COUNCIL INC.
To: ALBERTA INNOVATES - TECHNOLOGY FUTURES
Reel/Frame 025510/0527 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2010
From: VELCHEVA, MARGARITA; VIDMAR, JOHN; QUANDT, JURGEN
To: ALBERTA RSEARCH COUNCIL INC.
Reel/Frame 023932/0874 →